Document Classification

Section Type: RESULTS

Text: Despite comparable baseline clinical features among three groups, angiographic and procedural characteristics and outcomes differed significantly between patients receiving tirofiban treatment and controls, with respect to preprocedural (upstream : 28. 1 %, downstream : 7. 0 %, control : 5. 2 %, P < 0. 001) and postprocedural thrombolysis in myocardial infarction (TIMI) grade 3 flow of infarct-related artery (98. 2, 94. 7, 86. 2 %, P = 0. 03), TIMI myocardial perfusion grade 3 (75. 4, 70. 2, 53. 4 %, P = 0. 03), corrected TIMI frame count (20. 4 + / -5. 0, 23. 1 + / -5. 3, 32. 2 + / -6. 7, P < 0. 001), resolution of the sum of ST-segment elevation (6. 16 + / -1. 21, 6. 02 + / -1. 09, 4. 53 + / -2. 65 mm, P < 0. 001), peak value of creatine kinase-MB (218. 0 + / -72. 5, 224. 2 + / -69. 4, 255. 3 + / -77. 0 ng/ml, P = 0. 02) and troponin I (76. 0 + / -21. 5, 79. 8 + / -18. 7, 86. 4 + / -11. 0 ng/ml, P = 0. 007), and average hospital stay (10. 6 + / -5. 4, 12. 6 + / -4. 7, 14. 5 + / -6. 5 days, P = 0. 001).